<DOC>
	<DOC>NCT00620620</DOC>
	<brief_summary>The purpose of the study is to determine the safety, tolerability and pharmacokinetics of zaleplon delivered by the Staccato thermal aerosol system in healthy volunteers</brief_summary>
	<brief_title>Staccato Zaleplon Single Dose Pharmacokinetics</brief_title>
	<detailed_description />
	<mesh_term>Zaleplon</mesh_term>
	<criteria>Male and female subjects between the ages of 18 to 55 years, inclusive who are in good general health Subjects with a history of allergy or intolerance to zaleplon. Subjects who have any other disease or condition, by history, physical examination, or laboratory abnormalities that in the investigator's opinion, would present undue risk to the subject, or may confound the interpretation of study results.</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>55 Years</maximum_age>
	<verification_date>July 2013</verification_date>
	<keyword>Healthy adult volunteers</keyword>
</DOC>